India GLP-1 Receptor Agonist Market Scope Analysis By Product, Application, Route Of Administration, Distribution Channel And Forecast 2030


 San Francisco, 5 Novembers 2025: The Report India GLP-1 Receptor Agonist Market (2025 - 2030) Size, Share & Trends Analysis Report By Application (Diabetes, Obesity), By Route of Administration (Parenteral, Oral), By Product, By Distribution Channel, And Segment Forecasts

The India GLP-1 receptor agonist market size was estimated at USD 110.55 million in 2024 and is projected to grow at a CAGR of 34.3% from 2025 to 2030. The market is driven by the rising incidence of chronic conditions such as type 2 diabetes and obesity, increasing R&D activities for novel therapeutics, patent expiry, and the entry of generic alternatives. According to the International Diabetes Federation report of 2024, 8.98 million adults are prone to diabetes, and approximately 185 million people will succumb to diabetes by 2050 in India.

India has witnessed a significant rise in metabolic disorders due to rapid urbanization, sedentary lifestyles, and poor dietary habits. With rising obesity rates, the demand for effective treatments is continuously increasing. GLP-1 receptor agonists are recognized as a promising therapeutic class for managing both obesity and type 2 diabetes by improving insulin sensitivity and promoting weight loss. These drugs have gained popularity due to their proven efficacy, making them a sought-after treatment for millions suffering from these chronic conditions in India.

Access Research Report of India GLP-1 Receptor Agonist Market @ https://www.grandviewresearch.com/industry-analysis/india-glp-1-receptor-agonist-market-report

The Ministry of Ayush, India, has implemented various initiatives to combat obesity and promote weight management through Ayurveda. The All India Institute of Ayurveda (AIIA) in New Delhi offers specialized treatments such as Panchakarma, Ayurvedic medicines, dietary guidelines, and practicing yoga. The Central Council for Research in Ayurvedic Sciences (CCRAS) is primarily involved in formulating, developing, and promoting Ayurvedic medicines. CCRAS conducts clinical trials to evaluate the safety and efficacy of Ayurvedic formulations and practices in managing lifestyle-related disorders such as diabetes, hypertension, obesity, and stress-related ailments.

The Ayurswasthya Yojana supports community-based healthcare initiatives to address obesity and related lifestyle disorders. Through strategic collaboration with the Council of Scientific and Industrial Research (CSIR), the program integrates traditional Ayurvedic knowledge with modern scientific approaches, thereby advancing research and improving the prevention and management of these conditions.

Recent Developments

  • In April 2025, Sanofi India introduced its new diabetes medication, Soliqua, following marketing authorization from the Central Drugs Standard Control Organization (CDSCO) earlier last year. Soliqua is indicated for the treatment of adults with obesity and type 2 diabetes mellitus, aimed at improving glycemic control when used alongside diet and exercise.
  • In April 2025, Novo Nordisk announced that it would launch its blockbuster obesity medication, Wegovy (injectable semaglutide), in India by 2026 to manage diabetes and obesity.
  • In March 2025, Eli Lilly announced the launch of Mounjaro (Trizepatide), aglucagon-like peptide (GLP-1) receptor agonist in India. This medicine helps to manage blood sugar levels and control appetite for diabetes and obesity.

Key India GLP-1 Receptor Agonist Companies:

  • AstraZeneca
  • Novo Nordisk A/S
  • Eli Lilly and Co
  • Biocon
  • Sanofi
  • Glenmark Pharmaceuticals Ltd.
  • Cipla
  • Sun Pharmaceuticals Industries Ltd
  • Zydus Group
  • Lupin
  • Reddy’s Laboratories Ltd
  • Alkem
  • Piramal Pharma Limited

Comments

Post a Comment

Popular posts from this blog

Veterinary Services Market Projected To Raise At USD 212.73 Billion By 2030

Image
  San Francisco, 31 January 2025:  The Report  Veterinary Services Market  Size, Share & Trends Analysis Report By Service Type (Non-medical, Medical), By Animal Type (Companion, Production), By Region, And Segment Forecasts, 2023 - 2030 The global veterinary services market size is projected to reach USD 212.73 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 7.45% from 2023 to 2030.Some of the key factors propelling the market growth include increasing animal welfare activities, the rising need to enhance food security, increasing pet population, growing awareness about animal health & timely diagnosis & treatments, and increasing expenditure on animal healthcare services. For instance, according to the American Pet Products Association (APPA), overall spending in the U.S. pet industry was estimated at USD 136.8 billion in 2022. This was notably greater than the USD 123.6 billi...
Read more

Medical Device Regulatory Affairs Market Size Is Expected To Reach USD 8.6 Billion By 2028

Image
  San Francisco, 29 June 2021:   The Report  Medical Device Regulatory Affairs Market  Size, Share & Trends Analysis Report By Service (Legal Representation, Regulatory Consulting), By Type (Diagnostics, Therapeutics), By Service Provider, By Region, And Segment Forecasts, 2021 - 2028 The global medical device regulatory affairs market size is expected to reach USD 8.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.6% from 2021 to 2028. Technological advancements in medical devices such as AI/Machine learning, increasing trends of portable and smaller devices, and government regulations are driving the market. Medical equipment regulation is a vast and rapidly changing field that is often complicated by legal challenges. Even within one regulatory framework, legal terms and their definitions are not always consistent. As technology expands, software, machine learning, and algorithm...
Read more

Care Management Solutions Market Size Poised To Reach USD 33.26 Billion By 2030

Image
  San Francisco, 29 Oct 2024:  The Report  Care Management Solutions Market  Size, Share & Trends Analysis Report By Component (Software, Services), By Mode of Delivery (Web-based, Cloud-based, On premise), By End Use, By Region, And Segment Forecasts, 2024 - 2030 The global care management solutions market size is expected to reach USD 33.26 billion by 2030, registering a CAGR of 14.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Several initiatives are implemented to shift the risk burden from healthcare payers to healthcare providers. This shift enables the growing adoption of healthcare IT solutions, which include care management solutions, to enhance the delivery efficiency of healthcare services and minimize unnecessary expenses. Care management systems provide comprehensive solutions to improve decision-making, quality, and clinical outcomes. These patient-centered strategies enhance community health and help manage m...
Read more